NCT03055533

Brief Summary

Headsprout is a commercially available computer-based reading program that teaches children fundamental reading skills, including phonics, fluency, and comprehension. The Headsprout reading intervention has been shown to be effective with children with various levels of reading skills, but it has not been rigorously tested in children with autism spectrum disorder (ASD). The purpose of this study is to evaluate the effectiveness of Headsprout in a pilot sample of 18 children with ASD and reading delays to serve as a foundation for a larger, future randomized clinical trial (RCT). Eighteen participants will be included in the study and randomly assigned to one of two groups; the first group will immediately receive treatment with the Headsprout reading program and the second treatment group will receive treatment after 12 weeks. Treatment sessions will occur for one to two hours, two to four days a week, for twelve weeks. The participants who do not receive treatment immediately will be asked to complete reading assessments periodically throughout their wait time. Participation may occur in clinic or via telehealth.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 14, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 16, 2017

Completed
1.6 years until next milestone

Study Start

First participant enrolled

October 1, 2018

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 3, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 24, 2022

Completed
Last Updated

September 29, 2023

Status Verified

September 1, 2023

Enrollment Period

3.4 years

First QC Date

February 14, 2017

Last Update Submit

September 27, 2023

Conditions

Keywords

BehavioralSocialHeadsprout reading program

Outcome Measures

Primary Outcomes (1)

  • Change in Kaufman Test of Educational Achievement score (KTEA-3)

    The Kaufman Test of Educational Achievement (KTEA™-3) measures academic achievement and identifies learning disabilities for children in pre-kindergarten through grade 12. The KTEA™-3 evaluates reading, math, written language and oral language. For this study we will only use the reading portion of this assessment.

    Baseline and Week 12

Secondary Outcomes (1)

  • Change in the Dynamic Indicators of Basic Early Literacy Skills (DIBELS) assessment score

    Baseline and Week 12

Study Arms (2)

Immediate intervention with Headsprout reading program

EXPERIMENTAL

Participants randomized to this study arm will begin treatment with the Headsprout program right away. Reading assessments will occur at the beginning and end of 12 weeks of treatment. Participation may be in clinic or via telehealth.

Behavioral: Headsprout reading program

Delayed intervention

NO INTERVENTION

Participants randomized to this study arm will have reading assessments at the beginning and end of the study, but they will not begin treatment with the Headsprout program until after their participation in the study ends (12 weeks). Participation may be in clinic or via telehealth.

Interventions

Headsprout is a commercially available, computer-based program reading intervention that can be tailored to meet the individual needs of each child. Participants will have treatment sessions with a trained therapist lasting one to two hours, two to four days a week, for approximately twelve weeks.

Immediate intervention with Headsprout reading program

Eligibility Criteria

Age7 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Age 7.0 to 18.9
  • Confirmed clinical diagnosis of autism spectrum disorder (ASD)
  • Minimum score of 40 on the Early Echoic Skills Assessment (EESA), which assesses language skills
  • Minimum score of 20 on the Expressive Vocabulary Test (EVT), which assesses language skills
  • Display deficits in reading, testing at least one grade levels below current grade level on the Dynamic Indicators of Basic Early Literacy Skills (DIBELS)
  • English is primary language

You may not qualify if:

  • Currently receiving an individualized intervention for reading
  • Significant problem behavior

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Nebraska Medical Center

Omaha, Nebraska, 68198, United States

Location

MeSH Terms

Conditions

Autism Spectrum DisorderBehavior

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Study Officials

  • Bethany A Hansen, PhD, BCBA-D

    University of Nebraska

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 14, 2017

First Posted

February 16, 2017

Study Start

October 1, 2018

Primary Completion

March 3, 2022

Study Completion

June 24, 2022

Last Updated

September 29, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations